BioStock: Iconovo's CEO comments on the capital raise

Last week Iconovo carried out a directed share issue of 75 MSEK at a subscription price of 70 SEK per share. A large part of the proceeds from the issue will be used to expand the project portfolio in the field of innovative inhalation products and to build up the Nordic sales of pharmaceuticals through the pharmaceutical division Iconovo Pharma. BioStock contacted Iconovo’s CEO Johan Wäborg to find out more about which doors are opened thanks to the directed share issue.

Read the full article at biostock.se: 

https://www.biostock.se/en/iconovos-ceo-comments-on-the-capital-raise/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se